Chios mastic treatment of patients with active Crohn&rsquo;s disease

doi:10.3748/wjg.v13.i5.748

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2398)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

312

HTML

1723

Figures (1-4)

171

Tables (1-1)

192

Sum=2398

Feb 7, 2007 (publication date) through Jul 27, 2024

Times Cited of This Article

Times Cited (63)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Feb 7, 2007; 13(5): 748-753
Published online Feb 7, 2007. doi: 10.3748/wjg.v13.i5.748

Full Size Figure Download Figure

Figure 3 Plasma concentrations of interleukin-6 (IL-6) were suppressed in patients with active Crohn’s disease (n = 10) after 4-wk treatment with mastic caps (^aP < 0. 05). Horizontal bars represent the mean value (± SE).

Citation: Kaliora AC, Stathopoulou MG, Triantafillidis JK, Dedoussis GV, Andrikopoulos NK. Chios mastic treatment of patients with active Crohn’s disease. World J Gastroenterol 2007; 13(5): 748-753
URL: https://www.wjgnet.com/1007-9327/full/v13/i5/748.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i5.748